ProCE Banner Activity

Current Clinical Trials and Unique Small Molecule Targets in GBM

Slideset Download
In this downloadable slideset, Tom Mikkelsen, MD, FRCPC, examines optimal clinical trial approaches for GBM therapies.

Released: November 22, 2019

Expiration: November 20, 2020

No longer available for credit.

Share

Faculty

Tom Mikkelsen

Tom Mikkelsen, MD, FRCPC

Medical Director, Precision Medicine Program & Clinical Trials
Henry Ford Cancer Institute
Henry Ford Health System
Detroit, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma

Faculty Disclosure

Primary Author

Tom Mikkelsen, MD, FRCPC

Medical Director, Precision Medicine Program & Clinical Trials
Henry Ford Cancer Institute
Henry Ford Health System
Detroit, Michigan